← Home / BIODESIX INC (BDSX)
Stock Analysis
BIODESIX INC (BDSX)
BDSX
BDSX · Market data
21.20 -0.63%
Track BDSX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when BDSX price is:
52W Range Position
83%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 24.50. Holding above 19.13 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
19.13
↗
Break Above
Confirmation improves above resistance.
24.50
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 19.13
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
4
●
Financial Results
HIGH
Biodesix Announces First Quarter 2026 Results and Highlights
(Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the first quarter ended March 31, 2026.
8-K Filing • SEC EDGAR
What's Driving BDSX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 24.50 for confirmation and 19.13 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 20.67 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression
State
Forming
Compression
30%
RSI(14)
53.7
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 20.67 and resistance around 23.57. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
BDSX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$214.3M
Company size
EV
$238.7M
Debt-adjusted value
P/E
-6.7
Not meaningful
P/S
2.2
Low sales multiple
P/B
23.5
Very high
EV/Sales
2.5
Low sales multiple
EV/EBIT
-9.6
Not meaningful
P/FCF
-8.5
Not meaningful
FCF Yield
-11.72%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Pressured
💵 Revenue
25.55M
↗ Strong
📈 Net Income
-7.79M
↘ Negative
🧮 EPS (Basic)
-0.81
↘ Negative
BIODESIX INC
Related Opportunities